Europe Lab-on-a-Chip and Microarrays (Biochip) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Europe Lab-on-a-chip and Microarrays (Biochip) market is segmented By Type (Lab-on-a-Chip, Microarray), By Products, By Application, By End User and Country.

Market Snapshot

Market Snapshot
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 11.13 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Europe Lab-on-a-Chip and Microarrays (Biochip) Market are expected to witness a high CAGR growth during the forecast period, owing to the rising burden of chronic diseases, increasing applications of proteomics and genomics, and increasing demand for point of care testing. According to the Cancer Atlas, in 2018, approximately 3.9 million new cases of cancer and almost 1.9 million deaths were registered in Europe. Protein microarrays are one of the advancing tools which hold a promising future in cancer proteomics research. Therefore, these factors are expected to fuel market growth in the forecast period.

Scope of the report

As per the scope of the report, a biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that permits many tests to be performed at the same time, to achieve higher throughput and speed. Europe Lab-on-a-Chip and Microarrays (Biochip) Market are segmented By Type, By Product, By Application, By End User and Country.

By Type
By Products
Reagents & Consumables
Software and Services
By Application
Clinical Diagnostics
Drugs Discovery
Genomics and Proteomics
By End-User
Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostics Centres
Academic & Research Institute
By Country
United Kingdom
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

Microarrays are Expected to Exhibit a Significant Growth During the Forecast Period.

Microarrays are expected to show significant growth in the market during the forecast period, owing to the growing burden of morbidity and mortality due to chronic diseases and novel technologies developing in the market. 

According to the European Cardiovascular Disease Statistics, 2017, around 45% of all the death is caused due to cardiovascular diseases and almost 37% of deaths in the European Union are due to cardiovascular diseases. Microarrays are capable of profiling lncRNA and mRNA expression in atherosclerotic plaques. 

Furthermore, in 2019, Quotient Limited received an approval (CE Mark) for Immunohematology (IH) Microarray for use with its MosaiQ diagnostic platform. Therefore, the aforementioned factors are expected to boost the demand for microarrays in the market over the forecast period.

Europe Biochip market Trend.png

Competitive Landscape

Some of the key players in the Europe Lab-on-a-Chip and Microarrays (Biochip) Market are Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, GE Healthcare, ThermoFisher Scientific, F. Hoffmann-La Roche Ltd, BioMérieux and Illumina Inc.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Burden of Chronic Diseases due to Lifestyle Changes

      2. 4.2.2 Increasing Demand for Point-of-Care-Testing

      3. 4.2.3 Increasing Applications of Proteomics and Genomics in Cancer Research

    3. 4.3 Market Restraints

      1. 4.3.1 Design Constraints of Lab-on-chip Technology

      2. 4.3.2 Availability of Alternative Technologies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Type

      1. 5.1.1 Lab-on-a-Chip

      2. 5.1.2 Microarray

    2. 5.2 By Products

      1. 5.2.1 Instruments

      2. 5.2.2 Reagents & Consumables

      3. 5.2.3 Software and Services

    3. 5.3 By Application

      1. 5.3.1 Clinical Diagnostics

      2. 5.3.2 Drugs Discovery

      3. 5.3.3 Genomics and Proteomics

      4. 5.3.4 Others

    4. 5.4 By End-User

      1. 5.4.1 Biotechnology & Pharmaceutical Companies

      2. 5.4.2 Hospitals & Diagnostics Centres

      3. 5.4.3 Academic & Research Institute

    5. 5.5 By Country

      1. 5.5.1 Germany

      2. 5.5.2 United Kingdom

      3. 5.5.3 France

      4. 5.5.4 Italy

      5. 5.5.5 Spain

      6. 5.5.6 Rest of Europe


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Agilent Technologies

      3. 6.1.3 Bio-Rad Laboratories

      4. 6.1.4 Perkin Elmer Inc.

      5. 6.1.5 GE Healthcare

      6. 6.1.6 ThermoFisher Scientific

      7. 6.1.7 F. Hoffmann-La Roche Ltd

      8. 6.1.8 BioMerieux

      9. 6.1.9 Illumina Inc.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Lab-on-a-chip and Microarrays (Biochip) Market market is studied from 2018 - 2026.

The Europe Lab-on-a-chip and Microarrays (Biochip) Market is growing at a CAGR of 11.13% over the next 5 years.

ThermoFisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Abbott Laboratories, Perkin Elmer Inc. are the major companies operating in Europe Lab-on-a-chip and Microarrays (Biochip) Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!